2,000
Participants
Start Date
April 8, 2025
Primary Completion Date
April 7, 2026
Study Completion Date
October 2, 2026
Machine Learning-Based Clinical Decision Support: Overdose Prevention Alert (OPA) Intervention
In this study, researchers will pilot test an interruptive, ML CDS tool for opioid overdose risk across thirteen primary care clinics at the UF Health in Gainesville, FL. When a patient is identified by the ML algorithm as having an elevated overdose risk and a PCP signs an opioid prescription for the patient, an Opioid Prevention Alert (OPA) will be triggered. The alert will include the rationale for the patient's elevated risk status and provide three risk mitigation recommendations: optimizing pain treatment and mental health support, reviewing and discussing risks with the patient, and offering naloxone annually if no prior naloxone order is found in the patient's record. PCPs can also select an override reason, such as the patient already has naloxone, declined the intervention, is not present/it is not the right time, or the alert is not relevant/other comments, when appropriate.
RECRUITING
University of Florida Health Internal Medicine and Family Medicine, Gainesville
Collaborators (1)
National Institute on Drug Abuse (NIDA)
NIH
Applied Decision Science
UNKNOWN
University of Pittsburgh
OTHER